Striatin 3 and MAP4K4 cooperate towards oncogenic growth and tissue invasion in medulloblastoma
J. Migliavacca, B. Zuellig, C. Capdeville, M. A. Grotzer, M. Baumgartner
Abstract
MAP4K4 has been correlated with increased cell motility and reduced proliferation in mammalian cells. Consequences and regulation of this dichotomous functionality of MAP4K4 in tumor cells remained elusive. We find that MAP4K4 interacts with the STRN3 protein in medulloblastoma and that STRN3 and MAP4K4 exert opposing functions in Hippo tumor suppressor signaling and clonal growth. However, depletion of either STRN3 or MAP4K4 reduces migration and tissue invasion, and concomitant loss of both proteins halts tumor cell growth in the cerebellar tissue. Mechanistically, STRN3 couples MAP4K4 to the protein phosphatase 2A, which inactivates growth repressing activities of MAP4K4. In parallel, STRN3 enables growth factor-induced PKC{theta} activation and the direct phosphorylation of VASPS157 by MAP4K4, which are necessary for efficient migration and tissue invasion. Thus, STRN3 controls MAP4K4 functionality in growth factor-activated tumor cells, and the cooperation of the two proteins promotes invasiveness through nPKCs and VASP and increases proliferation via inactivation of Hippo signaling. Targeting of the STRN3-MAP4K4 cooperation could reactivate Hippo signaling and repress invasiveness in growth factor-driven tumors. Graphical abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=139 SRC="FIGDIR/small/442906v2_ufig1.gif" ALT="Figure 1"> View larger version (24K): org.highwire.dtl.DTLVardef@102b3c1org.highwire.dtl.DTLVardef@6753ceorg.highwire.dtl.DTLVardef@1af2ff5org.highwire.dtl.DTLVardef@759127_HPS_FORMAT_FIGEXP M_FIG C_FIG
02 /Specification & Classification
Click any tag to browse matching papers- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- MAP4 kinase-regulated reduced CLSTN1 expression in medulloblastoma is associated with increased invasiveness
Ece Sönmez, Shen Yan, … Martin Baumgartner·Scientific ReportsPeer-reviewed·Jan 6, 2025
- MAP4K inhibition by the CNS penetrant inhibitor famlasertib restrains medulloblastoma dissemination without developmental toxicity
Marc Thomas Schönholzer, Meng-Syuan Lin, … Martin Baumgartner·bioRxiv·Jul 23, 2026
- CD155 and EndoA1 mediate growth and tissue invasion downstream of MAP4K4 in medulloblastoma cells
C. Capdeville, L. Russo, … M. Baumgartner·bioRxiv·Aug 10, 2021
- CDK4 Restricts Triple-Negative Breast Cancer Cell Migration via Phosphorylation-Driven Activation of Myo9b RhoGAP Function
Kanishka Parashar, Laia Simó‐Riudalbas, … Lluis Fajas A·bioRxiv·Aug 6, 2025
- On the therapeutic potential of MAPK4 in triple-negative breast cancer
F. Boudghene-Stambouli, M. Soulez, … S. Meloche·bioRxiv·Aug 24, 2022
- Oncogenic Activation of AKT by MAPK6